Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7390668

Intracorporeal medicaments for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7387881

Detection and treatment of cancers of the liver

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7384909

Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to ant

The Board of Regents of the University of Texas System · Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7381405

Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7381404

Treatment for dry macular degeneration

The Regents of the University of California · Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378386

Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives

The Board of Regents of the University of Texas System · Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7374752

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368106

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7364726

Pharmaceutical composition for cancer treatment containing cells that express a membrane c

The Regents of the University of California · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7361680

Indole compounds useful for the treatment of cancer

The Regents of the University of California · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354582

Use of VEGF antagonists for the treatment of malignant gliomas

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354900

Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides

The Board of Regents of the University of Oklahoma · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354580

Method of administering and using VEGF inhibitors for the treatment of human cancer

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7344829

Methods for detecting the efficacy of anticancer treatments

The Board of Regents of the University of Texas System · Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7345030

Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of d

Third Military Medical University, Chinese People's Liberation Army, P.R. of China · Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7344711

Use of adenoviruses mutated in the VA genes for cancer treatment

ONCOLYTICS BIOTECH INC. · Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7335382

Compositions and methods for the treatment and prevention of cancer

Northwestern University · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7335640

Administration of hypocretin-1 for treatment of narcolepsy

The Regents of the University of California · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7326734

Treatment of bladder and urinary tract cancers

The Regents of the University of California · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7309483

Method of treatment using Tie2 ligand2

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7306799

Use of VEGF inhibitors for treatment of eye disorders

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7303747

Use of VEGF inhibitors for treatment of eye disorders

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7300915

Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain

The Regents of the University of California · Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7300650

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted